These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31016905)

  • 21. Applicability of Child-Turcotte-Pugh Score in Anticipating Post-ERCP Adverse Events in Patients With Cirrhosis: A Systematic Review and Meta-analysis.
    Alsakarneh S; Jaber F; Mohammed W; Almeqdadi M; Al-Ani A; Kilani Y; Abughazaleh S; Momani L; Miran MS; Ghoz H; Helzberg J; Clarkston W; Othman M
    J Clin Gastroenterol; 2024 Jul; 58(6):554-563. PubMed ID: 38687161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-ERCP Bleeding in the Era of Multiple Antiplatelet Agents.
    Oh HC; El Hajj II; Easler JJ; Watkins J; Fogel EL; McHenry L; Lehman GA; Choi JS; Kang H; Sherman S
    Gut Liver; 2018 Mar; 12(2):214-218. PubMed ID: 29212315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of propofol in cirrhotic patients undergoing colonoscopy and endoscopic retrograde cholangiography: results of a prospective controlled study.
    Fagà E; De Cento M; Giordanino C; Barletti C; Bruno M; Carucci P; De Angelis C; Venon WD; Musso A; Reggio D; Fagoonee S; Pellicano R; Ceretto S; Ciccone G; Rizzetto M; Saracco G
    Eur J Gastroenterol Hepatol; 2012 Jan; 24(1):70-6. PubMed ID: 21941187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What is the most adapted indication of prophylactic pancreatic duct stent within the high-risk group of post-endoscopic retrograde cholangiopancreatography pancreatitis? Using the propensity score analysis.
    Takenaka M; Fujita T; Sugiyama D; Masuda A; Shiomi H; Sugimoto M; Sanuki T; Hayakumo T; Azuma T; Kutsumi H
    J Hepatobiliary Pancreat Sci; 2014 Apr; 21(4):275-80. PubMed ID: 24039185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. End-stage renal disease is associated with increased post endoscopic retrograde cholangiopancreatography adverse events in hospitalized patients.
    Sawas T; Bazerbachi F; Haffar S; Cho WK; Levy MJ; Martin JA; Petersen BT; Topazian MD; Chandrasekhara V; Abu Dayyeh BK
    World J Gastroenterol; 2018 Nov; 24(41):4691-4697. PubMed ID: 30416316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of endoscopic retrograde cholangiopancreatography (ERCP) performed in patients with Periampullary duodenal diverticula (PAD).
    Zippi M; Traversa G; Pica R; De Felici I; Cassieri C; Marzano C; Occhigrossi G; Paoluzi P
    Clin Ter; 2014; 165(4):e291-4. PubMed ID: 25203345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. International Normalized Ratio Does Not Predict Gastrointestinal Bleeding After Endoscopic Retrograde Cholangiopancreatography in Patients With Cirrhosis.
    Adike A; Al-Qaisi M; Baffy NJ; Kosiorek H; Pannala R; Aqel B; Faigel DO; Harrison ME
    Gastroenterology Res; 2017 Jun; 10(3):177-181. PubMed ID: 28725305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of immunosuppression in post-endoscopic retrograde cholangiopancreatography pancreatitis after liver transplantation: a retrospective analysis.
    Law R; Leal C; Dayyeh BA; Leise MD; Balderramo D; Baron TH; Cardenas A
    Liver Transpl; 2013 Dec; 19(12):1354-60. PubMed ID: 24115362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrospective analysis of complications related to endoscopic retrograde cholangio-pancreatography in patients with cirrhosis
    Bernshteyn M; Hu L; Masood U; Sharma AV; Huang D; Sapkota B
    World J Hepatol; 2021 Apr; 13(4):472-482. PubMed ID: 33959228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of safety of non-anesthesiologist-assisted endoscopic retrograde cholangiopancreatography based on performance status in elderly patients.
    Park TY; Choi JS; Oh HC; Kim JW; Do JH; Jung YH
    J Gastroenterol Hepatol; 2014 Nov; 29(11):1943-8. PubMed ID: 24730577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of limited endoscopic sphincterotomy before self-expandable metal stent insertion for malignant biliary obstruction.
    Nam HS; Kang DH; Kim HW; Choi CW; Park SB; Kim SJ; Ryu DG
    World J Gastroenterol; 2017 Mar; 23(9):1627-1636. PubMed ID: 28321164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factor analysis of post-ERCP cholangitis: A single-center experience.
    Chen M; Wang L; Wang Y; Wei W; Yao YL; Ling TS; Shen YH; Zou XP
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):55-58. PubMed ID: 29428105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. National trends of endoscopic retrograde cholangiopancreatography utilization and outcomes in decompensated cirrhosis.
    Mehta D; Poojary P; Saha A; Kaur S; Patel S; Chawla L; Kumar A; Simoes P; Busayavalasa D; Nadkarni G; Sanaka M
    Surg Endosc; 2019 Jan; 33(1):169-178. PubMed ID: 29943059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complications after ERCP in liver transplant recipients.
    Balderramo D; Bordas JM; Sendino O; Abraldes JG; Navasa M; Llach J; Cardenas A
    Gastrointest Endosc; 2011 Aug; 74(2):285-94. PubMed ID: 21704993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention and management of adverse events of endoscopic retrograde cholangiopancreatography.
    Balmadrid B; Kozarek R
    Gastrointest Endosc Clin N Am; 2013 Apr; 23(2):385-403. PubMed ID: 23540966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
    Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
    World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A single institution's experience of infundibulotomy in patients taking antiplatelet agents: outcomes, safety and complications].
    Baek DH; Song GA; Kim DU; Kim GH; Lee BE; Jeon HK; Jhi JH; Bae JH; Lee HJ
    Korean J Gastroenterol; 2014 Apr; 63(4):216-22. PubMed ID: 24755746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk Factors for Post Endoscopic Retrograde Cholangiopancreatography Cholangitis.
    Boonsinsukh T; Viriyaroj V; Yodying H
    J Med Assoc Thai; 2016 Nov; 99 Suppl 8():S166-S170. PubMed ID: 29906028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endoscopic retrograde cholangiopancreatography in cirrhosis - a systematic review and meta-analysis focused on adverse events.
    Mashiana HS; Dhaliwal AS; Sayles H; Dhindsa B; Yoo JW; Wu Q; Singh S; Siddiqui AA; Ohning G; Girotra M; Adler DG
    World J Gastrointest Endosc; 2018 Nov; 10(11):354-366. PubMed ID: 30487946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of ERCP in patients with liver cirrhosis: a national database study.
    Navaneethan U; Njei B; Zhu X; Kommaraju K; Parsi MA; Varadarajulu S
    Endosc Int Open; 2017 Apr; 5(4):E303-E314. PubMed ID: 28393104
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.